Organ-sparing precision treatment for muscle-invasive bladder cancer

被引:1
|
作者
Li, Roger [1 ,2 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA
关键词
RADICAL CYSTECTOMY; PEMBROLIZUMAB;
D O I
10.1038/s41591-023-02575-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The response to neoadjuvant treatment can be used to stratify individuals with muscle-invasive bladder cancer according to their risk of progression, enabling bladder-sparing approaches for some - and heralding a shift from the existing one-size-fits-all approach.
引用
收藏
页码:2709 / 2710
页数:2
相关论文
共 50 条
  • [1] Organ-sparing precision treatment for muscle-invasive bladder cancer
    Roger Li
    [J]. Nature Medicine, 2023, 29 : 2709 - 2710
  • [2] Organ-sparing treatment in muscle-invasive bladder cancer
    Dunst, J
    Diestelhorst, A
    Kühn, R
    Müller, AC
    Scholz, HJ
    Fornara, P
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (10) : 632 - 637
  • [3] Organ-Sparing Strategies in Muscle-Invasive Bladder Cancer
    Witjes, J. Alfred
    Feikema, Astrid A. H.
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7833 - 7839
  • [4] Organ-Sparing Treatment in Muscle-Invasive Bladder CancerOrganerhaltende Behandlung des muskelinvasiven Harnblasenkarzinoms
    Jürgen Dunst
    Andrea Diestelhorst
    Reinhard Kühn
    Arndt-Christian Müller
    Hans-Jörg Scholz
    Paolo Fornara
    [J]. Strahlentherapie und Onkologie, 2005, 181 : 632 - 637
  • [5] Radical cystectomy vs organ-sparing trimodality treatment in muscle-invasive bladder cancer: a systematic review
    Arcangeli, S.
    Strigari, L.
    Arcangeli, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S354 - S354
  • [6] Organ-Sparing Multimodality Treatment for Muscle-Invasive Bladder Cancer: Can We Continue to Ignore the Evidence?
    Roedel, Claus
    Weiss, Christian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (34) : 3787 - U161
  • [7] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
    Matthew D. Galsky
    Siamak Daneshmand
    Sudeh Izadmehr
    Edgar Gonzalez-Kozlova
    Kevin G. Chan
    Sara Lewis
    Bassam El Achkar
    Tanya B. Dorff
    Jeremy Paul Cetnar
    Brock O. Neil
    Anishka D’Souza
    Ronac Mamtani
    Christos Kyriakopoulos
    Tomi Jun
    Mahalya Gogerly-Moragoda
    Rachel Brody
    Hui Xie
    Kai Nie
    Geoffrey Kelly
    Amir Horowitz
    Yayoi Kinoshita
    Ethan Ellis
    Yohei Nose
    Giorgio Ioannou
    Rafael Cabal
    Diane M. Del Valle
    G. Kenneth Haines
    Li Wang
    Kent W. Mouw
    Robert M. Samstein
    Reza Mehrazin
    Nina Bhardwaj
    Menggang Yu
    Qianqian Zhao
    Seunghee Kim-Schulze
    Robert Sebra
    Jun Zhu
    Sacha Gnjatic
    John Sfakianos
    Sumanta K. Pal
    [J]. Nature Medicine, 2023, 29 : 2825 - 2834
  • [8] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
    Galsky, Matthew D.
    Daneshmand, Siamak
    Izadmehr, Sudeh
    Gonzalez-Kozlova, Edgar
    Chan, Kevin G.
    Lewis, Sara
    Achkar, Bassam El
    Dorff, Tanya B.
    Cetnar, Jeremy Paul
    Neil, Brock O.
    D'Souza, Anishka
    Mamtani, Ronac
    Kyriakopoulos, Christos
    Jun, Tomi
    Gogerly-Moragoda, Mahalya
    Brody, Rachel
    Xie, Hui
    Nie, Kai
    Kelly, Geoffrey
    Horwitz, Amir
    Kinoshita, Yayoi
    Ellis, Ethan
    Nose, Yohei
    Ioannou, Giorgio
    Cabal, Rafael
    Haines, G. Kenneth
    Wang, Li
    Mouw, Kent W.
    Samstein, Robert M.
    Mehrazin, Reza
    Bhardwaj, Nina
    Yu, Menggang
    Zhao, Qianqian
    Kim-Schulze, Seunghee
    Sebra, Robert
    Zhu, Jun
    Gnjatic, Sacha
    Sfakianos, John
    Pal, Sumanta K.
    [J]. NATURE MEDICINE, 2023, 29 (11) : 2825 - +
  • [9] Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial
    Moschini, Marco
    Necchi, Andrea
    Montorsi, Francesco
    [J]. EUROPEAN UROLOGY, 2024, 85 (05) : 500 - 501
  • [10] Organ-sparing treatment of bladder cancer
    Niedworok, C.
    Shaleva, A.
    Ruebben, H.
    Stenzl, A.
    [J]. UROLOGE, 2016, 55 (05): : 609 - +